Poster Session
Welcome Reception & Posters (Prostate Cancer)

Thursday January 10, 2019 | 17:00 to 18:00
Room: Exhibit Hall

Presentations

A high baseline neutrophil-to-lymphocyte ratio in men with metastatic, castration-sensitive prostate cancer treated with chemohormonal therapy predicts a longer interval to castration resistance
Louis Everest, Canada

Poor bone health is common in men diagnosed with metastatic, castration-sensitive prostate cancer
Mr. Ihsan Albakri, Canada
SRI, Mississauga

Real-world use of radium-223 in patients with castration-resistant prostate cancer and bone metastases
Dr. Nathan C Wong, Canada
Memorial Sloan Kettering Cancer Center, Vancouver

IKKƐ inhibition by BX795 promotes a senescence phenotype in advanced prostate cancer
Miss Sophie Gilbert, Canada
Research center of CHUM, Montréal

Loss of PTEN decreases prostate cancer cell intrinsic type I interferon response
Dr. Robert Siemens, Canada
Quen's University, Kingston

Impact of autophagy in PARPi resistance in prostate cancer
Mr. Maxime Cahuzac, Canada
Centre de recherche du CHUM, Montréal

Real world Canadian experience with SpaceOAR (trademark) hydrogel rectal spacer for prostate cancer radiotherapy
Dr. Nawaid Usmani, Canada
Cross Cancer Instittute, Edmonton

Impact of putative chemopreventative agents on prostate cancer diagnosis
Dr. Hanan H Goldberg, Canada
Princess Margaret Cancer Center, Toronto

Prostate biopsy trends and results over a 20-year period in a high-volume tertiary center
Prof. Jaime O. Herrera-Caceres, Canada
Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto

Digital rectal examination variability before prostate biopsy
Prof. Jaime O. Herrera-Caceres, Canada
Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto

Email: info@cuos.ca
© 2019 CUOS 2019